Allergic rhinitis (AR) is a high-prevalence disease in many developed countries, affecting about 10–20 % of the general population (1–5). Several studies based on questionnaire and objective testing or medical exam
Allergic rhinitis (AR) is a noninfectious inflammatory disease of the nasal mucosa mediated by IgE a...
Sponsorships or competing interests that may be relevant to content are disclosed at the end of this...
Contains fulltext : 88489.pdf (Publisher’s version ) (Closed access
The goal of allergic rhinitis (AR) management is to achieve satisfactory symptom control to ensure g...
BACKGROUND: Critical examination of the quality and validity of available allergic rhinitis (AR) lit...
BackgroundCritical examination of the quality and validity of available allergic rhinitis (AR) liter...
Background: Critical examination of the quality and validity of available allergic rhinitis (AR) lit...
Critical examination of the quality and validity of available allergic rhinitis (AR) literature is n...
Allergic rhinitis (AR) is a global health problem because of its steadily increasing incidence and p...
Allergic rhinitis (AR) is one of the most common diseases and represents a global health problem, cu...
There are many obstacles in the path of effective allergy management, in general, and allergic rhini...
Allergic rhinitis is an extremely common disease worldwide, affecting 10% to 50% of the population. ...
Allergic rhinitis (AR) is a very common disease, caused by environmental aeroallergen, and clinicall...
Treatment for allergic rhinitis (AR) aims at reducing the burden of allergic inflammation, either by...
The past 30 years have seen an overall increase in the prevalence of allergic diseases (AD) among wh...
Allergic rhinitis (AR) is a noninfectious inflammatory disease of the nasal mucosa mediated by IgE a...
Sponsorships or competing interests that may be relevant to content are disclosed at the end of this...
Contains fulltext : 88489.pdf (Publisher’s version ) (Closed access
The goal of allergic rhinitis (AR) management is to achieve satisfactory symptom control to ensure g...
BACKGROUND: Critical examination of the quality and validity of available allergic rhinitis (AR) lit...
BackgroundCritical examination of the quality and validity of available allergic rhinitis (AR) liter...
Background: Critical examination of the quality and validity of available allergic rhinitis (AR) lit...
Critical examination of the quality and validity of available allergic rhinitis (AR) literature is n...
Allergic rhinitis (AR) is a global health problem because of its steadily increasing incidence and p...
Allergic rhinitis (AR) is one of the most common diseases and represents a global health problem, cu...
There are many obstacles in the path of effective allergy management, in general, and allergic rhini...
Allergic rhinitis is an extremely common disease worldwide, affecting 10% to 50% of the population. ...
Allergic rhinitis (AR) is a very common disease, caused by environmental aeroallergen, and clinicall...
Treatment for allergic rhinitis (AR) aims at reducing the burden of allergic inflammation, either by...
The past 30 years have seen an overall increase in the prevalence of allergic diseases (AD) among wh...
Allergic rhinitis (AR) is a noninfectious inflammatory disease of the nasal mucosa mediated by IgE a...
Sponsorships or competing interests that may be relevant to content are disclosed at the end of this...
Contains fulltext : 88489.pdf (Publisher’s version ) (Closed access